All In Biotech

Free tool

FAERS Monitor: Vagifem

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020908 or its brand name (Vagifem, Estradiol). Reports on generic versions are filed under their own applications.

Reports

51,288

Serious

25,836

50% of reports

Hospitalization

8,336

Death reported

1,050

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective4,227
  • headache3,188
  • fatigue3,185
  • nausea3,175
  • off label use2,652
  • pain2,331
  • diarrhoea2,200
  • dizziness1,956
  • arthralgia1,954
  • breast cancer female1,721
  • dyspnoea1,714
  • pruritus1,707
  • rash1,678
  • product adhesion issue1,541
  • malaise1,501

Reports by year received

View as table
YearReports
2004562
2005617
2006459
20071,513
2008501
2009689
20101,089
2011947
20121,316
20131,057
20141,323
20152,222
20162,721
20172,436
20182,790
20193,242
20203,207
20213,051
20223,260
20233,760
20243,898
20255,447
20265,180

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,002,871 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
breast cancer femaleSignal1,72128.226.842,226
product adhesion issueSignal1,54118.417.524,345
headacheSignal3,1882.12.01,859
arthralgia1,9541.91.8891
pruritus1,7071.81.7645
fatigue3,1851.71.6907
nausea3,1751.61.6836
dizziness1,9561.61.5461
rash1,6781.61.5364
pain2,3311.61.5478
malaise1,5011.41.3178
diarrhoea2,2001.41.3257
drug ineffective4,2271.31.3341
off label use2,6521.21.2131
dyspnoea1,7141.21.283

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.